Scrip Asks… What Does 2025 Hold For Biopharma? Part 1: The State Of The Biopharma Industry

Home / Media Center / Trinity in the News / Scrip Asks… What Does 2025 Hold For Biopharma? Part 1: The State Of The Biopharma Industry

Scrip  |  January 10, 2025

Trinity Life Sciences’ President and CEO, Leslie Orne, was quoted in an article by Scrip on the state of the biopharma industry in 2025.